ArticleOncotarget2017
Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.
Er-Bao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it